(+)-pilocarpine multiple interactions EXP 6480464 1 more ... CTD PMID:30542433 and PMID:31018114 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of GFAP protein CTD PMID:30542433 (+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of GFAP protein CTD PMID:25101675 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Atrazine results in increased expression of GFAP protein] CTD PMID:36282381 (R)-lipoic acid decreases expression ISO Gfap (Mus musculus) 6480464 Thioctic Acid results in decreased expression of GFAP mRNA CTD PMID:19555370 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of GFAP protein CTD PMID:18942769 (S)-amphetamine increases expression ISO Gfap (Mus musculus) 6480464 Dextroamphetamine results in increased expression of GFAP protein CTD PMID:15337264 (S)-nicotine increases expression ISO Gfap (Mus musculus) 6480464 Nicotine results in increased expression of GFAP mRNA CTD PMID:17997037 (S)-nicotine decreases expression ISO Gfap (Mus musculus) 6480464 Nicotine results in decreased expression of GFAP mRNA CTD PMID:21955143 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane decreases expression ISO GFAP (Homo sapiens) 6480464 2 and 2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased expression of GFAP mRNA CTD PMID:16580782 1,2-dichloroethane increases expression ISO Gfap (Mus musculus) 6480464 ethylene dichloride results in increased expression of GFAP mRNA CTD PMID:28960355 1,3,5-trinitro-1,3,5-triazinane increases expression EXP 6480464 cyclonite results in increased expression of GFAP mRNA CTD PMID:25559034 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Gfap (Mus musculus) 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:16809432 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO Gfap (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:19199078 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO GFAP (Homo sapiens) 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 results in increased expression of GFAP CTD PMID:15254749 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression EXP 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 results in decreased expression of GFAP mRNA CTD PMID:15994020 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] CTD PMID:15994020 17alpha-ethynylestradiol affects expression ISO Gfap (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of GFAP mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Gfap (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GFAP mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GFAP mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO Gfap (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of GFAP mRNA] CTD PMID:19031445 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of GFAP mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 Estradiol affects the reaction [Estrogens deficiency results in increased expression of GFAP protein alternative form] CTD PMID:30565903 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:33078273 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Gfap (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GFAP mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GFAP mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GFAP mRNA CTD PMID:19490992 and PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Gfap (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of GFAP mRNA CTD PMID:18343893 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Gfap (Mus musculus) 6480464 2 more ... CTD PMID:18343893 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-D increases expression EXP 6480464 2 and 4-Dichlorophenoxyacetic Acid results in increased expression of GFAP mRNA CTD PMID:22954530 2,4-dinitrobenzenesulfonic acid increases expression ISO Gfap (Mus musculus) 6480464 2 and 4-dinitrobenzenesulfonic acid results in increased expression of GFAP mRNA CTD PMID:30116771 2,4-dinitrobenzenesulfonic acid multiple interactions ISO Gfap (Mus musculus) 6480464 GR 159897 inhibits the reaction [2 and 4-dinitrobenzenesulfonic acid results in increased expression of GFAP mRNA] CTD PMID:30116771 2,5-hexanedione increases expression EXP 6480464 2 and 5-hexanedione results in increased expression of GFAP protein CTD PMID:19033394 2,5-hexanedione decreases expression EXP 6480464 2 and 5-hexanedione results in decreased expression of GFAP protein CTD PMID:19033394 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] and Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21863293 and PMID:21879721 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile increases expression EXP 6480464 Verapamil results in increased expression of GFAP mRNA CTD PMID:22954530 2-Ethylhexanoic acid decreases expression ISO Gfap (Mus musculus) 6480464 2-ethylhexanoic acid results in decreased expression of GFAP mRNA CTD PMID:30578912 2-palmitoylglycerol decreases expression ISO GFAP (Homo sapiens) 6480464 2-palmitoylglycerol results in decreased expression of GFAP mRNA CTD PMID:37199045 3',5'-cyclic AMP multiple interactions ISO GFAP (Homo sapiens) 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of GFAP mRNA CTD PMID:33713149 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Gfap (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of GFAP mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GFAP protein CTD PMID:16489401 3,4-methylenedioxymethamphetamine increases expression ISO Gfap (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GFAP protein CTD PMID:15337264 and PMID:19882200 3,4-methylenedioxymethamphetamine multiple interactions ISO Gfap (Mus musculus) 6480464 Caffeine promotes the reaction [N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GFAP protein] CTD PMID:19882200 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide multiple interactions ISO Gfap (Mus musculus) 6480464 Raclopride inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] CTD PMID:16088948 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression EXP 6480464 musk ketone results in increased expression of GFAP mRNA CTD PMID:22954530 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GFAP mRNA CTD PMID:36041667 5-fluorouracil increases expression ISO Gfap (Mus musculus) 6480464 Fluorouracil results in increased expression of GFAP protein CTD PMID:21296659 6-Cyano-7-nitroquinoxaline-2,3-dione multiple interactions EXP 6480464 6-Cyano-7-nitroquinoxaline-2 and 3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GFAP mRNA and Propylthiouracil results in increased expression of GFAP protein CTD PMID:22504374 and PMID:24780913 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of GFAP mRNA CTD PMID:24780913 6alpha-methylprednisolone decreases expression ISO GFAP (Homo sapiens) 6480464 Methylprednisolone results in decreased expression of GFAP protein CTD PMID:18509235 7-NITROINDAZOLE multiple interactions EXP 6480464 7-nitroindazole inhibits the reaction [Capsaicin results in increased expression of GFAP protein] more ... CTD PMID:20826152 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFAP mRNA CTD PMID:15994020 8-Br-cAMP multiple interactions EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] CTD PMID:15994020 8-OH-DPAT multiple interactions ISO Gfap (Mus musculus) 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [[Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of GFAP protein] CTD PMID:23692952 9-cis-retinoic acid increases expression ISO GFAP (Homo sapiens) 6480464 Alitretinoin results in increased expression of GFAP mRNA CTD PMID:36805303 abacavir increases expression ISO GFAP (Homo sapiens) 6480464 abacavir results in increased expression of GFAP protein CTD PMID:19358275 acetamide increases expression EXP 6480464 acetamide results in increased expression of GFAP mRNA CTD PMID:31881176 acetic acid decreases expression ISO Gfap (Mus musculus) 6480464 Acetic Acid results in decreased expression of GFAP protein CTD PMID:21296659 acetylsalicylic acid decreases expression ISO GFAP (Homo sapiens) 6480464 Aspirin results in decreased expression of GFAP mRNA and Aspirin results in decreased expression of GFAP protein CTD PMID:16516312 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of GFAP mRNA CTD PMID:22954530 acetylsalicylic acid decreases expression ISO Gfap (Mus musculus) 6480464 Aspirin results in decreased expression of GFAP mRNA CTD PMID:21353610 acrolein increases expression EXP 6480464 Acrolein results in increased expression of GFAP protein CTD PMID:31639409 acrolein multiple interactions EXP 6480464 3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2 and 2-dimethyl-1-methylcarbamoyl-1-propyl)amide inhibits the reaction [Acrolein results in increased expression of GFAP protein] CTD PMID:31639409 acrylamide increases expression ISO GFAP (Homo sapiens) 6480464 Acrylamide results in increased expression of GFAP protein CTD PMID:19426797 acrylamide decreases expression ISO GFAP (Homo sapiens) 6480464 Acrylamide results in decreased expression of GFAP mRNA and Acrylamide results in decreased expression of GFAP protein CTD PMID:32763439 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GFAP mRNA CTD PMID:36328537 Aflatoxin B2 alpha decreases methylation ISO GFAP (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of GFAP exon CTD PMID:30157460 agmatine multiple interactions ISO Gfap (Mus musculus) 6480464 Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein] and NOS2 gene mutant form promotes the reaction [Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein]] CTD PMID:24070732 agomelatine multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 all-trans-retinoic acid multiple interactions ISO GFAP (Homo sapiens) 6480464 [Tretinoin co-treated with Paclitaxel] results in increased expression of GFAP protein CTD PMID:18098270 all-trans-retinoic acid decreases expression ISO GFAP (Homo sapiens) 6480464 Tretinoin results in decreased expression of GFAP protein CTD PMID:36805303 all-trans-retinoic acid multiple interactions ISO Gfap (Mus musculus) 6480464 Tretinoin inhibits the reaction [Dietary Fats promotes the reaction [Lead results in increased expression of GFAP protein]] and Tretinoin inhibits the reaction [Lead promotes the reaction [Dietary Fats results in increased expression of GFAP protein]] CTD PMID:34742682 all-trans-retinoic acid affects expression ISO GFAP (Homo sapiens) 6480464 Tretinoin affects the expression of GFAP mRNA CTD PMID:31600526 and PMID:36805303 all-trans-retinoic acid increases expression ISO Gfap (Mus musculus) 6480464 Tretinoin results in increased expression of GFAP mRNA and Tretinoin results in increased expression of GFAP protein CTD PMID:11311979 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of GFAP protein CTD PMID:16944780 all-trans-retinoic acid increases expression ISO GFAP (Homo sapiens) 6480464 Tretinoin results in increased expression of GFAP mRNA and Tretinoin results in increased expression of GFAP protein CTD PMID:17960384 more ... alpha,alpha-trehalose multiple interactions ISO Gfap (Mus musculus) 6480464 Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 alpha-D-galactose increases expression EXP 6480464 Galactose results in increased expression of GFAP protein CTD PMID:34673010 alpha-D-galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein] and Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 aluminium atom increases expression EXP 6480464 Aluminum results in increased expression of GFAP protein CTD PMID:16545059 aluminium atom multiple interactions ISO Gfap (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of GFAP protein CTD PMID:31363819 aluminium atom multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] CTD PMID:16545059 aluminium(0) increases expression EXP 6480464 Aluminum results in increased expression of GFAP protein CTD PMID:16545059 aluminium(0) multiple interactions ISO Gfap (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of GFAP protein CTD PMID:31363819 aluminium(0) multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] CTD PMID:16545059 amentoflavone multiple interactions ISO Gfap (Mus musculus) 6480464 amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28185818 aminoguanidine multiple interactions EXP 6480464 [7-nitroindazole co-treated with pimagedine] promotes the reaction [Capsaicin results in increased expression of GFAP protein] more ... CTD PMID:20826152 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of GFAP mRNA CTD PMID:22954530 and PMID:25659768 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of GFAP mRNA CTD PMID:22954530 ammonia multiple interactions ISO GFAP (Homo sapiens) 6480464 IL1B protein promotes the reaction [Ammonia results in decreased expression of GFAP mRNA] CTD PMID:20217200 ammonia decreases expression ISO GFAP (Homo sapiens) 6480464 Ammonia results in decreased expression of GFAP mRNA CTD PMID:20217200 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of GFAP mRNA and Ammonium Chloride results in decreased expression of GFAP protein CTD PMID:16483693 amphetamine increases expression ISO GFAP (Homo sapiens) 6480464 Amphetamine results in increased expression of GFAP protein CTD PMID:15814102 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of GFAP mRNA and Amphetamine results in increased expression of GFAP protein CTD PMID:15183010 and PMID:20223277 antimony(0) multiple interactions ISO Gfap (Mus musculus) 6480464 [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein CTD PMID:34571074 antimony(0) multiple interactions EXP 6480464 666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein] more ... CTD PMID:34571074 apocynin multiple interactions ISO Gfap (Mus musculus) 6480464 acetovanillone inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of GFAP protein] CTD PMID:30797899 aristolochic acid A increases expression ISO GFAP (Homo sapiens) 6480464 aristolochic acid I results in increased expression of GFAP mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO Gfap (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of GFAP mRNA CTD PMID:34265337 arsane affects methylation ISO GFAP (Homo sapiens) 6480464 Arsenic affects the methylation of GFAP gene CTD PMID:25304211 arsenic atom affects methylation ISO GFAP (Homo sapiens) 6480464 Arsenic affects the methylation of GFAP gene CTD PMID:25304211 astaxanthin decreases expression ISO Gfap (Mus musculus) 6480464 astaxanthine results in decreased expression of GFAP mRNA CTD PMID:19555370 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of GFAP mRNA and Atrazine results in decreased expression of GFAP protein CTD PMID:34994930 and PMID:36841081 atrazine decreases expression ISO GFAP (Homo sapiens) 6480464 Atrazine results in decreased expression of GFAP mRNA CTD PMID:34146662 atrazine increases expression EXP 6480464 Atrazine results in increased expression of GFAP protein CTD PMID:36282381 atrazine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Atrazine results in increased expression of GFAP protein] CTD PMID:36282381 azithromycin increases expression ISO Gfap (Mus musculus) 6480464 Azithromycin results in increased expression of GFAP mRNA CTD PMID:37995777 benzo[a]pyrene decreases expression ISO Gfap (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of GFAP mRNA CTD PMID:20127859 benzo[a]pyrene increases methylation ISO GFAP (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of GFAP 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO GFAP (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of GFAP mRNA CTD PMID:22316170 benzo[e]pyrene decreases methylation ISO GFAP (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of GFAP exon CTD PMID:30157460 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [Bortezomib results in increased expression of GFAP mRNA] CTD PMID:35121005 bis(2-ethylhexyl) phthalate increases expression ISO Gfap (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of GFAP protein CTD PMID:28934723 bisphenol A multiple interactions ISO Gfap (Mus musculus) 6480464 Tamoxifen inhibits the reaction [bisphenol A results in increased expression of GFAP protein] CTD PMID:16860915 bisphenol A decreases expression ISO GFAP (Homo sapiens) 6480464 bisphenol A results in decreased expression of GFAP protein CTD PMID:35069845 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GFAP mRNA CTD PMID:30816183 more ... bisphenol A decreases methylation ISO Gfap (Mus musculus) 6480464 bisphenol A results in decreased methylation of GFAP promoter CTD PMID:27312807 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GFAP mRNA CTD PMID:25181051 bisphenol A increases expression ISO Gfap (Mus musculus) 6480464 bisphenol A results in increased expression of GFAP mRNA and bisphenol A results in increased expression of GFAP protein CTD PMID:16684133 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GFAP mRNA and Curcumin inhibits the reaction [bisphenol A results in increased expression of GFAP mRNA] CTD PMID:25963729 and PMID:36041667 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GFAP mRNA and bisphenol A results in increased expression of GFAP protein CTD PMID:25381574 more ... bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GFAP mRNA CTD PMID:36041667 bortezomib multiple interactions EXP 6480464 Berberine inhibits the reaction [Bortezomib results in increased expression of GFAP mRNA] CTD PMID:35121005 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of GFAP mRNA CTD PMID:35121005 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of GFAP protein CTD PMID:28903499 bromochloroacetic acid decreases expression ISO Gfap (Mus musculus) 6480464 bromochloroacetic acid results in decreased expression of GFAP protein CTD PMID:21296659 cadmium dichloride increases expression ISO GFAP (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of GFAP protein CTD PMID:21796402 cadmium dichloride increases expression ISO Gfap (Mus musculus) 6480464 Cadmium Chloride results in increased expression of GFAP mRNA CTD PMID:24982889 cadmium dichloride multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:20829427 more ... cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GFAP protein CTD PMID:20829427 caffeine multiple interactions ISO Gfap (Mus musculus) 6480464 Caffeine promotes the reaction [N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GFAP protein] CTD PMID:19882200 caffeine multiple interactions EXP 6480464 Caffeine inhibits the reaction [aluminum chloride results in increased expression of GFAP protein] CTD PMID:26339337 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of GFAP mRNA CTD PMID:17293106 calcitriol affects expression ISO Gfap (Mus musculus) 6480464 Calcitriol affects the expression of GFAP mRNA CTD PMID:15138306 calcium atom multiple interactions EXP 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] and Calcium deficiency inhibits the reaction [Ethanol results in increased expression of GFAP protein] CTD PMID:17888892 and PMID:21879721 calcium(0) multiple interactions EXP 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] and Calcium deficiency inhibits the reaction [Ethanol results in increased expression of GFAP protein] CTD PMID:17888892 and PMID:21879721 calyculin a multiple interactions EXP 6480464 calyculin A inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 cannabidiol multiple interactions ISO GFAP (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in increased expression of GFAP protein CTD PMID:30096889 capsaicin increases expression ISO GFAP (Homo sapiens) 6480464 Capsaicin results in increased expression of GFAP mRNA CTD PMID:18405923 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of GFAP protein CTD PMID:20826152 capsaicin multiple interactions EXP 6480464 7-nitroindazole inhibits the reaction [Capsaicin results in increased expression of GFAP protein] more ... CTD PMID:19285962 and PMID:20826152 capsazepine multiple interactions EXP 6480464 capsazepine inhibits the reaction [Capsaicin results in increased expression of GFAP protein] CTD PMID:20826152 capsazepine multiple interactions ISO Gfap (Mus musculus) 6480464 capsazepine inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] CTD PMID:32652086 captan multiple interactions ISO Gfap (Mus musculus) 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 carbendazim increases expression EXP 6480464 carbendazim results in increased expression of GFAP protein CTD PMID:35513110 carbofuran decreases expression EXP 6480464 Carbofuran results in decreased expression of GFAP protein CTD PMID:22240977 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of GFAP mRNA CTD PMID:28982980 carbonyl sulfide affects expression EXP 6480464 carbonyl sulfide affects the expression of GFAP mRNA CTD PMID:19395590 carmustine multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carmustine results in decreased expression of GFAP protein] CTD PMID:17572393 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of GFAP protein CTD PMID:17572393 carmustine decreases expression ISO GFAP (Homo sapiens) 6480464 Carmustine results in decreased expression of GFAP mRNA CTD PMID:15980968 carvacrol multiple interactions EXP 6480464 carvacrol inhibits the reaction [propiconazole results in increased expression of GFAP protein] CTD PMID:29852196 chlordecone increases expression ISO Gfap (Mus musculus) 6480464 Chlordecone results in increased expression of GFAP mRNA CTD PMID:29980752 chlorpromazine affects expression EXP 6480464 Chlorpromazine affects the expression of GFAP mRNA CTD PMID:31324950 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of GFAP mRNA CTD PMID:17452286 and PMID:20691718 chlorpyrifos multiple interactions ISO Gfap (Mus musculus) 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 chlorpyrifos increases expression ISO GFAP (Homo sapiens) 6480464 Chlorpyrifos results in increased expression of GFAP mRNA and Chlorpyrifos results in increased expression of GFAP protein CTD PMID:31136966 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein more ... CTD PMID:30236991 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of GFAP mRNA CTD PMID:16675515 choline multiple interactions ISO Gfap (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene CTD PMID:20938992 chrysin multiple interactions EXP 6480464 chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP mRNA] and chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP protein] CTD PMID:33121995 Citreoviridin affects expression ISO Gfap (Mus musculus) 6480464 citreoviridin affects the expression of GFAP mRNA CTD PMID:30071239 clofibrate multiple interactions ISO Gfap (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA] CTD PMID:17585979 clotrimazole increases expression ISO GFAP (Homo sapiens) 6480464 Clotrimazole results in increased expression of GFAP protein CTD PMID:10223459 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of GFAP protein CTD PMID:18585900 clozapine increases expression EXP 6480464 Clozapine results in increased expression of GFAP mRNA CTD PMID:19441803 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of GFAP mRNA and cobaltous chloride results in increased expression of GFAP protein CTD PMID:23978538 and PMID:30551423 cobalt dichloride multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [cobaltous chloride results in increased expression of GFAP protein] CTD PMID:30551423 cocaine increases expression ISO GFAP (Homo sapiens) 6480464 Cocaine results in increased expression of GFAP protein CTD PMID:15814102 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of GFAP protein CTD PMID:11391778 cocaine affects expression EXP 6480464 Cocaine affects the expression of GFAP mRNA and Cocaine affects the expression of GFAP protein CTD PMID:12670315 and PMID:20187946 cocaine affects expression ISO Gfap (Mus musculus) 6480464 Cocaine affects the expression of GFAP protein CTD PMID:11882367 coenzyme Q10 decreases expression ISO Gfap (Mus musculus) 6480464 coenzyme Q10 results in decreased expression of GFAP mRNA CTD PMID:19555370 coenzyme Q10 multiple interactions EXP 6480464 [Oxygen co-treated with coenzyme Q10] results in decreased expression of GFAP protein CTD PMID:35212449 colforsin daropate hydrochloride decreases expression ISO GFAP (Homo sapiens) 6480464 Colforsin results in decreased expression of GFAP protein CTD PMID:34897981 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of GFAP mRNA CTD PMID:26033743 copper atom multiple interactions ISO Gfap (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of GFAP protein CTD PMID:36775208 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of GFAP mRNA CTD PMID:26033743 copper(0) multiple interactions ISO Gfap (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of GFAP protein CTD PMID:36775208 copper(II) sulfate multiple interactions ISO Gfap (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of GFAP protein CTD PMID:36775208 Cuprizon multiple interactions ISO Gfap (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of GFAP mRNA] CTD PMID:19031445 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of GFAP mRNA and Cuprizone results in increased expression of GFAP protein CTD PMID:27523638 Cuprizon increases expression ISO Gfap (Mus musculus) 6480464 Cuprizone results in increased expression of GFAP mRNA and Cuprizone results in increased expression of GFAP protein CTD PMID:19031445 and PMID:30468814 curcumin decreases expression ISO Gfap (Mus musculus) 6480464 Curcumin results in decreased expression of GFAP mRNA CTD PMID:19555370 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of GFAP mRNA CTD PMID:25963729 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [bisphenol A results in increased expression of GFAP mRNA] CTD PMID:25963729 cyanocob(III)alamin multiple interactions EXP 6480464 Vitamin B 12 inhibits the reaction [Streptozocin results in increased expression of GFAP protein] CTD PMID:38049026 Cyanoginosin increases degradation EXP 6480464 microcystin analog results in increased degradation of GFAP protein CTD PMID:27864109 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of GFAP protein CTD PMID:37060950 cyprodinil multiple interactions ISO GFAP (Homo sapiens) 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] CTD PMID:31939705 cyprodinil multiple interactions ISO Gfap (Mus musculus) 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein CTD PMID:31939705 dabigatran decreases expression ISO Gfap (Mus musculus) 6480464 Dabigatran results in decreased expression of GFAP protein CTD PMID:27397090 dantrolene multiple interactions EXP 6480464 Dantrolene inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] and Dantrolene inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21863293 and PMID:21879721 dexamethasone increases expression ISO GFAP (Homo sapiens) 6480464 Dexamethasone results in increased expression of GFAP protein CTD PMID:22048647 diazinon affects expression EXP 6480464 Diazinon affects the expression of GFAP mRNA CTD PMID:17452286 dieldrin multiple interactions ISO Gfap (Mus musculus) 6480464 Dieldrin promotes the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:16809432 digoxin increases expression EXP 6480464 Digoxin results in increased expression of GFAP mRNA CTD PMID:22954530 dihydrogen multiple interactions EXP 6480464 Hydrogen inhibits the reaction [[Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein] CTD PMID:30236991 dimethoate increases expression EXP 6480464 Dimethoate results in increased expression of GFAP mRNA and Dimethoate results in increased expression of GFAP protein CTD PMID:21941777 dioxygen increases expression ISO Gfap (Mus musculus) 6480464 Oxygen results in increased expression of GFAP protein CTD PMID:25203536 dioxygen multiple interactions EXP 6480464 [Oxygen co-treated with coenzyme Q10] results in decreased expression of GFAP protein more ... CTD PMID:25727173 and PMID:35212449 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO Gfap (Mus musculus) 6480464 [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein CTD PMID:34571074 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions EXP 6480464 666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein] more ... CTD PMID:34571074 diprotium multiple interactions EXP 6480464 Hydrogen inhibits the reaction [[Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein] CTD PMID:30236991 disodium selenite multiple interactions ISO Gfap (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of GFAP mRNA] CTD PMID:17997286 disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of GFAP mRNA CTD PMID:18209489 dizocilpine maleate multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 dopaminechrome (enol form) decreases expression EXP 6480464 aminochrome 1 results in decreased expression of GFAP protein CTD PMID:29588162 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of GFAP protein CTD PMID:28818578 doxorubicin multiple interactions EXP 6480464 galangin inhibits the reaction [Doxorubicin results in increased expression of GFAP protein] CTD PMID:35843304 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of GFAP protein CTD PMID:35843304 ebselen increases phosphorylation EXP 6480464 ebselen results in increased phosphorylation of GFAP protein CTD PMID:27282967 emodin multiple interactions EXP 6480464 Emodin inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein] and Emodin inhibits the reaction [TNF protein results in increased expression of GFAP protein] CTD PMID:36184831 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GFAP mRNA CTD PMID:29391264 ethanol affects expression EXP 6480464 Ethanol affects the expression of GFAP mRNA and Ethanol affects the expression of GFAP protein CTD PMID:17262233 and PMID:34547370 ethanol affects splicing ISO Gfap (Mus musculus) 6480464 Ethanol affects the splicing of GFAP mRNA CTD PMID:30319688 ethanol increases expression ISO Gfap (Mus musculus) 6480464 Ethanol results in increased expression of GFAP mRNA and Ethanol results in increased expression of GFAP protein CTD PMID:23500890 and PMID:30319688 ethanol multiple interactions ISO Gfap (Mus musculus) 6480464 Ethanol promotes the reaction [Dietary Fats results in increased expression of GFAP mRNA] and TLR4 gene mutant form inhibits the reaction [Ethanol results in increased expression of GFAP protein] CTD PMID:23500890 and PMID:35863473 ethanol increases expression EXP 6480464 Ethanol results in increased expression of GFAP protein CTD PMID:17888892 ethanol multiple interactions EXP 6480464 [cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester co-treated with Ethanol] results in increased expression of GFAP mRNA more ... CTD PMID:17888892 and PMID:30098312 ethanol increases expression ISO GFAP (Homo sapiens) 6480464 Ethanol results in increased expression of GFAP protein CTD PMID:20621659 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of GFAP mRNA and Ethanol results in decreased expression of GFAP protein CTD PMID:16770775 and PMID:20837132 ethanol decreases expression ISO Gfap (Mus musculus) 6480464 Ethanol results in decreased expression of GFAP mRNA CTD PMID:21955143 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:21879721 fenitrothion multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of GFAP protein] CTD PMID:31173782 fenitrothion increases expression EXP 6480464 Fenitrothion results in increased expression of GFAP protein CTD PMID:31173782 finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [Butyrates results in increased expression of GFAP mRNA] more ... CTD PMID:19360904 fipronil increases expression EXP 6480464 fipronil results in increased expression of GFAP protein CTD PMID:34352653 fisetin multiple interactions EXP 6480464 fisetin inhibits the reaction [methylmercuric chloride results in increased expression of GFAP protein] CTD PMID:30890323 fluoxetine increases response to substance ISO Gfap (Mus musculus) 6480464 GFAP protein results in increased susceptibility to Fluoxetine CTD PMID:22113448 fluoxetine increases expression ISO Gfap (Mus musculus) 6480464 Fluoxetine results in increased expression of GFAP mRNA and Fluoxetine results in increased expression of GFAP protein CTD PMID:20857517 folic acid multiple interactions ISO Gfap (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene more ... CTD PMID:20938992 and PMID:30502384 folic acid decreases expression ISO GFAP (Homo sapiens) 6480464 Folic Acid results in decreased expression of GFAP mRNA CTD PMID:21867686 folic acid decreases expression ISO Gfap (Mus musculus) 6480464 Folic Acid results in decreased expression of GFAP mRNA CTD PMID:25629700 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA] CTD PMID:30502384 furan decreases expression EXP 6480464 furan results in decreased expression of GFAP mRNA CTD PMID:25539665 furan increases expression EXP 6480464 furan results in increased expression of GFAP mRNA CTD PMID:25539665 galactose increases expression EXP 6480464 Galactose results in increased expression of GFAP protein CTD PMID:34673010 galactose multiple interactions EXP 6480464 agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein] and Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 galangin multiple interactions EXP 6480464 galangin inhibits the reaction [Doxorubicin results in increased expression of GFAP protein] CTD PMID:35843304 gamma-aminobutyric acid increases expression EXP 6480464 gamma-Aminobutyric Acid results in increased expression of GFAP protein CTD PMID:17845906 gefitinib multiple interactions EXP 6480464 gefitinib inhibits the reaction [HBEGF protein inhibits the reaction [sodium arsenite results in decreased expression of GFAP protein]] CTD PMID:29228391 glufosinate increases expression ISO Gfap (Mus musculus) 6480464 phosphinothricin results in increased expression of GFAP mRNA and phosphinothricin results in increased expression of GFAP protein CTD PMID:27031874 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of GFAP mRNA CTD PMID:24915197 glycidol increases expression EXP 6480464 glycidol results in increased expression of GFAP mRNA CTD PMID:24395379 glyphosate increases expression ISO GFAP (Homo sapiens) 6480464 Glyphosate results in increased expression of GFAP mRNA and Glyphosate results in increased expression of GFAP protein CTD PMID:35485992 haloperidol decreases expression ISO GFAP (Homo sapiens) 6480464 Haloperidol results in decreased expression of GFAP protein CTD PMID:34122009 hydrogen peroxide multiple interactions ISO Gfap (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of GFAP mRNA] CTD PMID:17997286 hydrogen peroxide increases expression ISO Gfap (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of GFAP mRNA CTD PMID:17997286 hydrogen sulfide increases expression ISO Gfap (Mus musculus) 6480464 Hydrogen Sulfide results in increased expression of GFAP mRNA CTD PMID:31843631 ibuprofen multiple interactions EXP 6480464 Ibuprofen inhibits the reaction [Streptozocin results in increased expression of GFAP mRNA] and Ibuprofen inhibits the reaction [Streptozocin results in increased expression of GFAP protein] CTD PMID:24333387 ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of GFAP protein CTD PMID:31722249 ifosfamide multiple interactions EXP 6480464 morin inhibits the reaction [Ifosfamide results in increased expression of GFAP protein] CTD PMID:31722249 imidacloprid increases expression EXP 6480464 imidacloprid results in increased expression of GFAP protein CTD PMID:18080902 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 (22R more ... CTD PMID:19850110 isoliquiritigenin multiple interactions ISO Gfap (Mus musculus) 6480464 isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] CTD PMID:19834288 isoniazide multiple interactions EXP 6480464 chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP mRNA] and chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP protein] CTD PMID:33121995 isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of GFAP mRNA and Isoniazid results in increased expression of GFAP protein CTD PMID:33121995 ivermectin decreases expression ISO GFAP (Homo sapiens) 6480464 Ivermectin results in decreased expression of GFAP protein CTD PMID:32959892 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of GFAP mRNA and Kainic Acid results in increased expression of GFAP protein CTD PMID:18711747 more ... kainic acid multiple interactions ISO GFAP (Homo sapiens) 6480464 EPO protein inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:18711747 kainic acid multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:32057834 kainic acid multiple interactions ISO Gfap (Mus musculus) 6480464 PTGS2 affects the reaction [Kainic Acid results in increased expression of GFAP mRNA] CTD PMID:21589914 kainic acid increases expression ISO Gfap (Mus musculus) 6480464 Kainic Acid results in increased expression of GFAP mRNA and Kainic Acid results in increased expression of GFAP protein CTD PMID:17997037 and PMID:21589914 ketamine increases expression EXP 6480464 Ketamine results in increased expression of GFAP mRNA CTD PMID:20080153 KN-93 multiple interactions EXP 6480464 KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21879721 KN-93 multiple interactions ISO Gfap (Mus musculus) 6480464 KN 93 inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:34286406 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of GFAP protein CTD PMID:15372504 L-ascorbic acid multiple interactions ISO Gfap (Mus musculus) 6480464 Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:34286406 L-ascorbic acid multiple interactions ISO GFAP (Homo sapiens) 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of GFAP mRNA CTD PMID:33713149 L-methionine multiple interactions ISO Gfap (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene CTD PMID:20938992 lead diacetate multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:20829427 more ... lead diacetate multiple interactions ISO Gfap (Mus musculus) 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of GFAP mRNA] CTD PMID:36539177 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GFAP mRNA and lead acetate results in increased expression of GFAP protein CTD PMID:17047031 more ... lead diacetate increases expression ISO Gfap (Mus musculus) 6480464 lead acetate results in increased expression of GFAP mRNA and lead acetate results in increased expression of GFAP protein CTD PMID:21322097 and PMID:36539177 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of GFAP protein CTD PMID:20829427 lead nitrate multiple interactions EXP 6480464 Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP mRNA] and Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP protein] CTD PMID:24987671 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of GFAP mRNA and lead nitrate results in increased expression of GFAP protein CTD PMID:24987671 lead(0) affects expression ISO GFAP (Homo sapiens) 6480464 Lead affects the expression of GFAP mRNA CTD PMID:28903495 lead(0) multiple interactions ISO GFAP (Homo sapiens) 6480464 N and N'-Bis(2-mercaptoethyl)isophthalamide inhibits the reaction [Lead results in increased expression of GFAP protein] CTD PMID:34165617 lead(0) increases expression ISO GFAP (Homo sapiens) 6480464 Lead results in increased expression of GFAP protein CTD PMID:34165617 lead(0) increases expression ISO Gfap (Mus musculus) 6480464 Lead results in increased expression of GFAP mRNA and Lead results in increased expression of GFAP protein CTD PMID:34742682 lead(0) multiple interactions ISO Gfap (Mus musculus) 6480464 Dietary Fats promotes the reaction [Lead results in increased expression of GFAP mRNA] more ... CTD PMID:34742682 lead(II) chloride decreases expression EXP 6480464 lead chloride results in decreased expression of GFAP mRNA CTD PMID:19651682 lipoic acid decreases expression ISO Gfap (Mus musculus) 6480464 Thioctic Acid results in decreased expression of GFAP mRNA CTD PMID:19555370 lipopolysaccharide increases expression ISO Gfap (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of GFAP protein CTD PMID:26954031 and PMID:34474083 lipopolysaccharide multiple interactions ISO Gfap (Mus musculus) 6480464 AGT protein modified form promotes the reaction [FXN gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of GFAP protein]] more ... CTD PMID:26954031 and PMID:34474083 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of GFAP protein CTD PMID:12967722 more ... lipopolysaccharide multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Lipopolysaccharides] results in increased expression of GFAP protein more ... CTD PMID:24481447 more ... lithium chloride multiple interactions ISO GFAP (Homo sapiens) 6480464 Lithium Chloride inhibits the reaction [wogonin results in increased expression of GFAP protein] CTD PMID:23872260 lithium chloride multiple interactions EXP 6480464 [Lithium Chloride co-treated with Pilocarpine] results in increased expression of GFAP mRNA more ... CTD PMID:23872260 and PMID:31018114 luteolin multiple interactions ISO Gfap (Mus musculus) 6480464 Luteolin inhibits the reaction [Carbon Tetrachloride results in increased expression of GFAP protein] CTD PMID:19747501 lycopene decreases expression ISO Gfap (Mus musculus) 6480464 lycopene results in decreased expression of GFAP mRNA CTD PMID:19555370 lycopene multiple interactions EXP 6480464 Lycopene inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein] CTD PMID:32544411 Magnolol multiple interactions ISO Gfap (Mus musculus) 6480464 magnolol inhibits the reaction [trimethyltin results in increased expression of GFAP protein] CTD PMID:26756313 maneb multiple interactions ISO Gfap (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in increased expression of GFAP protein and acetovanillone inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of GFAP protein] CTD PMID:30797899 manganese atom affects expression EXP 6480464 Manganese affects the expression of GFAP protein CTD PMID:24885898 manganese atom increases expression ISO Gfap (Mus musculus) 6480464 Manganese results in increased expression of GFAP mRNA and Manganese results in increased expression of GFAP protein CTD PMID:23832297 manganese atom increases expression EXP 6480464 Manganese results in increased expression of GFAP mRNA and Manganese results in increased expression of GFAP protein CTD PMID:19782702 and PMID:20224926 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of GFAP mRNA CTD PMID:20224926 manganese(0) affects expression EXP 6480464 Manganese affects the expression of GFAP protein CTD PMID:24885898 manganese(0) increases expression ISO Gfap (Mus musculus) 6480464 Manganese results in increased expression of GFAP mRNA and Manganese results in increased expression of GFAP protein CTD PMID:23832297 manganese(0) increases expression EXP 6480464 Manganese results in increased expression of GFAP mRNA and Manganese results in increased expression of GFAP protein CTD PMID:19782702 and PMID:20224926 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of GFAP mRNA CTD PMID:20224926 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of GFAP protein CTD PMID:12009774 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of GFAP protein CTD PMID:12106697 and PMID:24060432 manganese(II) chloride multiple interactions ISO Gfap (Mus musculus) 6480464 Melatonin inhibits the reaction [manganese chloride results in increased expression of GFAP protein] CTD PMID:25288107 manganese(II) chloride increases expression ISO Gfap (Mus musculus) 6480464 manganese chloride results in increased expression of GFAP protein CTD PMID:25288107 and PMID:28539244 manganese(II) chloride decreases expression ISO Gfap (Mus musculus) 6480464 manganese chloride results in decreased expression of GFAP protein CTD PMID:24969583 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carmustine results in decreased expression of GFAP protein] and Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:17572393 and PMID:34673010 melatonin multiple interactions ISO Gfap (Mus musculus) 6480464 Melatonin inhibits the reaction [manganese chloride results in increased expression of GFAP protein] CTD PMID:25288107 memantine multiple interactions EXP 6480464 Memantine inhibits the reaction [Streptozocin results in increased expression of GFAP mRNA] and Memantine inhibits the reaction [Streptozocin results in increased expression of GFAP protein] CTD PMID:24333387 memantine multiple interactions ISO Gfap (Mus musculus) 6480464 Memantine inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein] CTD PMID:34474083 mepanipyrim multiple interactions ISO Gfap (Mus musculus) 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein CTD PMID:31939705 mepanipyrim multiple interactions ISO GFAP (Homo sapiens) 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] CTD PMID:31939705 metformin multiple interactions ISO Gfap (Mus musculus) 6480464 Metformin inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] CTD PMID:32652086 methamphetamine multiple interactions ISO Gfap (Mus musculus) 6480464 3-((3 more ... CTD PMID:16088948 more ... methamphetamine increases expression ISO Gfap (Mus musculus) 6480464 Methamphetamine results in increased expression of GFAP mRNA and Methamphetamine results in increased expression of GFAP protein CTD PMID:12766323 more ... methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GFAP mRNA and Methamphetamine results in increased expression of GFAP protein CTD PMID:10773198 more ... methamphetamine affects expression EXP 6480464 Methamphetamine affects the expression of GFAP protein CTD PMID:17262233 methapyrilene decreases methylation ISO GFAP (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of GFAP exon CTD PMID:30157460 methimazole increases expression EXP 6480464 Methimazole results in increased expression of GFAP protein CTD PMID:22504374 methionine sulfoximine increases expression EXP 6480464 Methionine Sulfoximine results in increased expression of GFAP protein CTD PMID:2565645 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of GFAP mRNA and Methotrexate results in decreased expression of GFAP protein CTD PMID:30502384 methotrexate decreases expression ISO Gfap (Mus musculus) 6480464 Methotrexate results in decreased expression of GFAP protein CTD PMID:30502384 methotrexate multiple interactions ISO Gfap (Mus musculus) 6480464 Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA] and Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP protein] CTD PMID:30502384 methotrexate multiple interactions EXP 6480464 DHFR protein inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA] and Folic Acid inhibits the reaction [Methotrexate results in decreased expression of GFAP mRNA] CTD PMID:30502384 methylene blue multiple interactions ISO Gfap (Mus musculus) 6480464 Methylene Blue inhibits the reaction [MAPT protein mutant form results in increased expression of GFAP mRNA] and Methylene Blue inhibits the reaction [MAPT protein mutant form results in increased expression of GFAP protein] CTD PMID:24556215 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of GFAP mRNA and methylmercuric chloride results in increased expression of GFAP protein CTD PMID:28821999 more ... methylmercury chloride affects expression ISO Gfap (Mus musculus) 6480464 methylmercuric chloride affects the expression of GFAP protein CTD PMID:33301842 methylmercury chloride multiple interactions ISO Gfap (Mus musculus) 6480464 [GHRL protein co-treated with methylmercuric chloride] affects the expression of GFAP protein CTD PMID:33301842 methylmercury chloride multiple interactions EXP 6480464 fisetin inhibits the reaction [methylmercuric chloride results in increased expression of GFAP protein] CTD PMID:30890323 methylmercury chloride increases expression ISO GFAP (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of GFAP mRNA CTD PMID:27729293 microcystin LF increases degradation EXP 6480464 microcystin-LF results in increased degradation of GFAP protein CTD PMID:27864109 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of GFAP protein CTD PMID:22430071 monocrotaline affects expression EXP 6480464 Monocrotaline affects the expression of GFAP protein CTD PMID:21781985 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of GFAP mRNA CTD PMID:20928830 morin multiple interactions EXP 6480464 morin inhibits the reaction [Ifosfamide results in increased expression of GFAP protein] CTD PMID:31722249 morphine decreases expression ISO Gfap (Mus musculus) 6480464 Morphine results in decreased expression of GFAP mRNA CTD PMID:21955143 morphine multiple interactions EXP 6480464 [lead acetate co-treated with Morphine] results in increased expression of GFAP mRNA CTD PMID:26478469 N,N-diethyl-m-toluamide increases expression EXP 6480464 DEET results in increased expression of GFAP protein CTD PMID:11681848 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:11681848 N-acetyl-L-cysteine multiple interactions ISO Gfap (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] CTD PMID:28499986 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Fenitrothion results in increased expression of GFAP protein] CTD PMID:31173782 N-methyl-4-phenylpyridinium increases expression ISO Gfap (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GFAP mRNA CTD PMID:15140182 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of GFAP protein CTD PMID:18155124 N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of GFAP mRNA CTD PMID:28688903 N-nitrosodiethylamine affects expression EXP 6480464 Diethylnitrosamine affects the expression of GFAP mRNA CTD PMID:20387270 NADP zwitterion multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:32057834 NADP(+) multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of GFAP protein] CTD PMID:32057834 nicotine increases expression ISO Gfap (Mus musculus) 6480464 Nicotine results in increased expression of GFAP mRNA CTD PMID:17997037 nicotine decreases expression ISO Gfap (Mus musculus) 6480464 Nicotine results in decreased expression of GFAP mRNA CTD PMID:21955143 nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 nitric oxide decreases expression EXP 6480464 Nitric Oxide deficiency results in decreased expression of GFAP protein CTD PMID:15763998 Nonylphenol multiple interactions EXP 6480464 thymoquinone inhibits the reaction [nonylphenol results in increased expression of GFAP protein] CTD PMID:37466128 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of GFAP protein CTD PMID:37466128 O-acetyl-L-carnitine decreases expression ISO Gfap (Mus musculus) 6480464 Acetylcarnitine results in decreased expression of GFAP mRNA CTD PMID:19555370 ochratoxin A multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:15994020 and PMID:24792326 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of GFAP mRNA and ochratoxin A results in decreased expression of GFAP protein CTD PMID:15994020 more ... olanzapine multiple interactions ISO Gfap (Mus musculus) 6480464 capsazepine inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] more ... CTD PMID:32652086 olanzapine increases expression ISO Gfap (Mus musculus) 6480464 Olanzapine results in increased expression of GFAP mRNA CTD PMID:32652086 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of GFAP mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 Oxaliplatin results in increased expression of GFAP protein CTD PMID:32544411 and PMID:36184831 oxaliplatin multiple interactions EXP 6480464 Emodin inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein] and Lycopene inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein] CTD PMID:32544411 and PMID:36184831 oxidopamine multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Oxidopamine results in increased expression of GFAP protein] and Rosiglitazone promotes the reaction [Oxidopamine results in increased expression of GFAP protein] CTD PMID:22842585 and PMID:34302886 oxidopamine decreases expression EXP 6480464 Oxidopamine results in decreased expression of GFAP protein CTD PMID:24486959 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of GFAP protein CTD PMID:22842585 and PMID:34302886 ozone multiple interactions ISO Gfap (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GFAP mRNA CTD PMID:27106289 paclitaxel multiple interactions ISO GFAP (Homo sapiens) 6480464 [Tretinoin co-treated with Paclitaxel] results in increased expression of GFAP protein CTD PMID:18098270 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of GFAP protein CTD PMID:16854522 and PMID:17005179 paclitaxel increases expression ISO GFAP (Homo sapiens) 6480464 Paclitaxel results in increased expression of GFAP protein CTD PMID:18098270 paracetamol multiple interactions ISO Gfap (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA] CTD PMID:17585979 paraquat increases expression ISO Gfap (Mus musculus) 6480464 Paraquat results in increased expression of GFAP protein CTD PMID:21688324 paraquat affects expression ISO GFAP (Homo sapiens) 6480464 Paraquat affects the expression of GFAP mRNA CTD PMID:29454966 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GFAP mRNA and Paraquat results in increased expression of GFAP protein CTD PMID:24521700 and PMID:28467894 paraquat increases expression ISO GFAP (Homo sapiens) 6480464 Paraquat results in increased expression of GFAP mRNA and Paraquat results in increased expression of GFAP protein CTD PMID:25314302 more ... paraquat multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased expression of GFAP protein CTD PMID:24376630 paraquat multiple interactions ISO Gfap (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in increased expression of GFAP protein more ... CTD PMID:21688324 and PMID:30797899 perfluorohexanesulfonic acid decreases expression ISO GFAP (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO GFAP (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of GFAP protein CTD PMID:20937303 perfluorooctane-1-sulfonic acid decreases expression ISO GFAP (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO GFAP (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of GFAP mRNA CTD PMID:25812627 permethrin increases expression ISO Gfap (Mus musculus) 6480464 Permethrin results in increased expression of GFAP protein CTD PMID:14555407 permethrin multiple interactions ISO Gfap (Mus musculus) 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:27984134 permethrin increases expression EXP 6480464 Permethrin results in increased expression of GFAP protein CTD PMID:11681848 permethrin multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:11681848 phencyclidine increases expression ISO Gfap (Mus musculus) 6480464 Phencyclidine results in increased expression of GFAP mRNA CTD PMID:17266109 phenethyl caffeate multiple interactions EXP 6480464 NGFR protein affects the susceptibility to [caffeic acid phenethyl ester results in increased expression of GFAP protein] CTD PMID:20836997 phenethyl caffeate increases expression EXP 6480464 caffeic acid phenethyl ester results in increased expression of GFAP protein CTD PMID:20836997 Phenoxybenzamine increases expression EXP 6480464 Phenoxybenzamine results in increased expression of GFAP protein CTD PMID:17845906 physostigmine multiple interactions ISO Gfap (Mus musculus) 6480464 Physostigmine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] CTD PMID:28499986 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of GFAP mRNA CTD PMID:27317300 potassium chloride increases expression EXP 6480464 Potassium Chloride results in increased expression of GFAP protein CTD PMID:27422357 probenecid multiple interactions ISO Gfap (Mus musculus) 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 and PMID:28807673 probucol multiple interactions EXP 6480464 NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein]] and Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein] CTD PMID:28881715 progesterone multiple interactions ISO Gfap (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] promotes the reaction [Cuprizone results in increased expression of GFAP mRNA] CTD PMID:19031445 progesterone increases expression EXP 6480464 Progesterone results in increased expression of GFAP mRNA CTD PMID:19360904 and PMID:21770760 progesterone decreases expression ISO Gfap (Mus musculus) 6480464 Progesterone results in decreased expression of GFAP protein CTD PMID:23157231 progesterone multiple interactions EXP 6480464 Finasteride inhibits the reaction [Progesterone results in increased expression of GFAP mRNA] CTD PMID:19360904 propiconazole multiple interactions EXP 6480464 carvacrol inhibits the reaction [propiconazole results in increased expression of GFAP protein] CTD PMID:29852196 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of GFAP protein CTD PMID:29852196 propionic acid increases expression EXP 6480464 propionic acid results in increased expression of GFAP protein CTD PMID:16950524 Pyridostigmine bromide multiple interactions ISO Gfap (Mus musculus) 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of GFAP protein CTD PMID:27984134 pyrimethanil multiple interactions ISO Gfap (Mus musculus) 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein CTD PMID:31939705 pyrimethanil multiple interactions ISO GFAP (Homo sapiens) 6480464 [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] CTD PMID:31939705 pyrithiamine increases expression EXP 6480464 Pyrithiamine results in increased expression of GFAP protein CTD PMID:27984051 pyrrolidine dithiocarbamate multiple interactions ISO Gfap (Mus musculus) 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of GFAP mRNA] CTD PMID:36539177 pyrroloquinoline quinone increases expression ISO GFAP (Homo sapiens) 6480464 PQQ Cofactor results in increased expression of GFAP mRNA CTD PMID:28578007 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:33038355 reactive oxygen species multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased expression of GFAP protein CTD PMID:24376630 Repaglinide multiple interactions EXP 6480464 repaglinide inhibits the reaction [Rotenone results in increased expression of GFAP protein] CTD PMID:36538285 resveratrol multiple interactions ISO Gfap (Mus musculus) 6480464 Resveratrol inhibits the reaction [Aluminum Chloride results in increased expression of GFAP protein] more ... CTD PMID:17581637 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of GFAP protein CTD PMID:27093858 resveratrol multiple interactions ISO GFAP (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of GFAP mRNA more ... CTD PMID:22530672 and PMID:23557933 resveratrol increases expression ISO GFAP (Homo sapiens) 6480464 resveratrol results in increased expression of GFAP protein CTD PMID:22530672 and PMID:23651583 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of GFAP protein] more ... CTD PMID:17888892 more ... rimonabant decreases expression ISO Gfap (Mus musculus) 6480464 Rimonabant results in decreased expression of GFAP protein CTD PMID:21373835 rimonabant multiple interactions ISO Gfap (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dronabinol results in increased expression of GFAP mRNA] CTD PMID:36529297 rotenone increases expression EXP 6480464 Rotenone results in increased expression of GFAP protein CTD PMID:23098804 more ... rotenone decreases expression ISO Gfap (Mus musculus) 6480464 Rotenone results in decreased expression of GFAP protein CTD PMID:35919817 rotenone multiple interactions ISO Gfap (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Rotenone] which affects the expression of GFAP mRNA CTD PMID:36400285 rotenone multiple interactions EXP 6480464 caryophyllene inhibits the reaction [Rotenone results in increased expression of GFAP protein] and repaglinide inhibits the reaction [Rotenone results in increased expression of GFAP protein] CTD PMID:27316720 and PMID:36538285 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of GFAP mRNA CTD PMID:28374803 ruthenium red multiple interactions ISO Gfap (Mus musculus) 6480464 Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA] CTD PMID:32652086 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 (22R more ... CTD PMID:19850110 sarin multiple interactions ISO Gfap (Mus musculus) 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [[Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of GFAP protein] and [Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of GFAP protein CTD PMID:23692952 sarin increases expression EXP 6480464 Sarin results in increased expression of GFAP protein CTD PMID:27639427 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA] and SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein] CTD PMID:34571074 SB 431542 increases expression ISO GFAP (Homo sapiens) 6480464 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of GFAP protein CTD PMID:25670856 SCH 23390 multiple interactions ISO Gfap (Mus musculus) 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] CTD PMID:16088948 scopolamine multiple interactions ISO Gfap (Mus musculus) 6480464 Ashwagandha inhibits the reaction [Scopolamine results in decreased expression of GFAP mRNA] more ... CTD PMID:22096544 scopolamine decreases expression ISO Gfap (Mus musculus) 6480464 Scopolamine results in decreased expression of GFAP mRNA and Scopolamine results in decreased expression of GFAP protein CTD PMID:22096544 sodium arsenite decreases expression ISO GFAP (Homo sapiens) 6480464 sodium arsenite results in decreased expression of GFAP mRNA CTD PMID:19615344 sodium arsenite decreases expression ISO Gfap (Mus musculus) 6480464 sodium arsenite results in decreased expression of GFAP mRNA CTD PMID:37682722 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GFAP mRNA and sodium arsenite results in decreased expression of GFAP protein CTD PMID:20829427 and PMID:29228391 sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:20829427 more ... sodium chloride decreases expression EXP 6480464 Sodium Chloride results in decreased expression of GFAP protein CTD PMID:16280599 sodium chloride increases expression EXP 6480464 Sodium Chloride results in increased expression of GFAP mRNA CTD PMID:22954530 Soman increases expression EXP 6480464 Soman results in increased expression of GFAP mRNA CTD PMID:19281266 staurosporine multiple interactions EXP 6480464 Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21879721 sterigmatocystin decreases expression EXP 6480464 Sterigmatocystin results in decreased expression of GFAP mRNA CTD PMID:34126181 streptozocin multiple interactions EXP 6480464 Ibuprofen inhibits the reaction [Streptozocin results in increased expression of GFAP mRNA] more ... CTD PMID:24333387 and PMID:38049026 streptozocin multiple interactions ISO Gfap (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] and Physostigmine inhibits the reaction [Streptozocin results in decreased expression of GFAP protein] CTD PMID:28499986 streptozocin decreases expression ISO Gfap (Mus musculus) 6480464 Streptozocin results in decreased expression of GFAP protein CTD PMID:28499986 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of GFAP mRNA and Streptozocin results in increased expression of GFAP protein CTD PMID:24333387 and PMID:38049026 strychnine increases expression EXP 6480464 Strychnine results in increased expression of GFAP mRNA CTD PMID:22954530 tadalafil multiple interactions ISO Gfap (Mus musculus) 6480464 Tadalafil inhibits the reaction [Thioacetamide results in increased expression of GFAP protein] CTD PMID:31323263 tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of GFAP CTD PMID:19182380 tamoxifen affects expression ISO Gfap (Mus musculus) 6480464 Tamoxifen affects the expression of GFAP mRNA CTD PMID:17555576 tamoxifen multiple interactions ISO Gfap (Mus musculus) 6480464 Tamoxifen inhibits the reaction [bisphenol A results in increased expression of GFAP protein] CTD PMID:16860915 Tanshinone I increases expression ISO GFAP (Homo sapiens) 6480464 tanshinone results in increased expression of GFAP mRNA and tanshinone results in increased expression of GFAP protein CTD PMID:16955220 telmisartan multiple interactions ISO Gfap (Mus musculus) 6480464 telmisartan inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23747572 telmisartan decreases expression EXP 6480464 Telmisartan results in decreased expression of GFAP protein CTD PMID:29909460 temozolomide multiple interactions ISO GFAP (Homo sapiens) 6480464 resveratrol promotes the reaction [temozolomide results in increased expression of GFAP protein] and temozolomide promotes the reaction [resveratrol results in increased expression of GFAP protein] CTD PMID:22530672 temozolomide increases expression ISO GFAP (Homo sapiens) 6480464 temozolomide results in increased expression of GFAP protein CTD PMID:22530672 terbutaline increases expression EXP 6480464 Terbutaline results in increased expression of GFAP protein CTD PMID:14610225 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of GFAP protein CTD PMID:24394546 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of GFAP protein CTD PMID:24394546 testosterone decreases expression ISO Gfap (Mus musculus) 6480464 Testosterone results in decreased expression of GFAP mRNA CTD PMID:19693291 testosterone increases expression ISO GFAP (Homo sapiens) 6480464 Testosterone results in increased expression of GFAP mRNA CTD PMID:33359661 tetrachloroethene decreases expression EXP 6480464 Tetrachloroethylene results in decreased expression of GFAP protein CTD PMID:8372046 tetrachloromethane increases expression ISO Gfap (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of GFAP protein CTD PMID:19747501 tetrachloromethane multiple interactions ISO Gfap (Mus musculus) 6480464 Luteolin inhibits the reaction [Carbon Tetrachloride results in increased expression of GFAP protein] CTD PMID:19747501 thiacloprid multiple interactions ISO Gfap (Mus musculus) 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 thioacetamide increases expression ISO Gfap (Mus musculus) 6480464 Thioacetamide results in increased expression of GFAP protein CTD PMID:31323263 thioacetamide multiple interactions EXP 6480464 alloin inhibits the reaction [Thioacetamide results in increased expression of GFAP protein] CTD PMID:30380640 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GFAP mRNA and Thioacetamide results in increased expression of GFAP protein CTD PMID:30380640 and PMID:34492290 thioacetamide multiple interactions ISO Gfap (Mus musculus) 6480464 Tadalafil inhibits the reaction [Thioacetamide results in increased expression of GFAP protein] CTD PMID:31323263 thiophanate-methyl multiple interactions ISO Gfap (Mus musculus) 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 thymoquinone multiple interactions EXP 6480464 thymoquinone inhibits the reaction [nonylphenol results in increased expression of GFAP protein] CTD PMID:37466128 toluene increases expression EXP 6480464 Toluene results in increased expression of GFAP mRNA and Toluene results in increased expression of GFAP protein CTD PMID:10987130 and PMID:22166486 toluene increases expression ISO Gfap (Mus musculus) 6480464 Toluene results in increased expression of GFAP mRNA CTD PMID:21381054 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of GFAP protein CTD PMID:23743147 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of GFAP protein CTD PMID:23743147 and PMID:26079211 tributylstannane multiple interactions EXP 6480464 Phycocyanin inhibits the reaction [tributyltin results in increased expression of GFAP protein] CTD PMID:26079211 trichostatin A multiple interactions EXP 6480464 Finasteride inhibits the reaction [trichostatin A results in increased expression of GFAP mRNA] and Finasteride inhibits the reaction [trichostatin A results in increased expression of GFAP protein] CTD PMID:19360904 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of GFAP mRNA and trichostatin A results in increased expression of GFAP protein CTD PMID:19360904 triclosan decreases expression ISO GFAP (Homo sapiens) 6480464 Triclosan results in decreased expression of GFAP mRNA CTD PMID:30510588 trimethyltin increases expression ISO Gfap (Mus musculus) 6480464 trimethyltin results in increased expression of GFAP mRNA and trimethyltin results in increased expression of GFAP protein CTD PMID:24002884 and PMID:26756313 trimethyltin increases expression ISO GFAP (Homo sapiens) 6480464 trimethyltin results in increased expression of GFAP mRNA CTD PMID:27729293 trimethyltin multiple interactions ISO Gfap (Mus musculus) 6480464 magnolol inhibits the reaction [trimethyltin results in increased expression of GFAP protein] CTD PMID:26756313 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of GFAP mRNA CTD PMID:33078273 triptonide increases expression ISO Gfap (Mus musculus) 6480464 triptonide results in increased expression of GFAP mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of GFAP mRNA and troglitazone results in decreased expression of GFAP protein CTD PMID:24481447 troglitazone multiple interactions EXP 6480464 [Troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 U-73122 multiple interactions EXP 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:21879721 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GFAP mRNA and Valproic Acid results in decreased expression of GFAP protein CTD PMID:18585900 and PMID:22954530 valproic acid decreases expression ISO Gfap (Mus musculus) 6480464 Valproic Acid results in decreased expression of GFAP mRNA CTD PMID:30578912 valproic acid increases methylation ISO GFAP (Homo sapiens) 6480464 Valproic Acid results in increased methylation of GFAP gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GFAP mRNA and Valproic Acid results in increased expression of GFAP protein CTD PMID:19360904 valproic acid multiple interactions EXP 6480464 Finasteride inhibits the reaction [Valproic Acid results in increased expression of GFAP mRNA] and Finasteride inhibits the reaction [Valproic Acid results in increased expression of GFAP protein] CTD PMID:19360904 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of GFAP mRNA CTD PMID:25423262 verapamil multiple interactions EXP 6480464 Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] and Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] CTD PMID:21863293 and PMID:21879721 verapamil increases expression EXP 6480464 Verapamil results in increased expression of GFAP mRNA CTD PMID:22954530 vincristine multiple interactions ISO Gfap (Mus musculus) 6480464 Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GFAP protein] and KN 93 inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:34286406 vincristine increases expression EXP 6480464 Vincristine results in increased expression of GFAP protein CTD PMID:33038355 vincristine multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of GFAP protein] CTD PMID:33038355 vincristine increases expression ISO Gfap (Mus musculus) 6480464 Vincristine results in increased expression of GFAP protein CTD PMID:34286406 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] CTD PMID:16545059 warfarin increases expression ISO Gfap (Mus musculus) 6480464 Warfarin results in increased expression of GFAP mRNA and Warfarin results in increased expression of GFAP protein CTD PMID:27397090 wogonin multiple interactions ISO GFAP (Homo sapiens) 6480464 Lithium Chloride inhibits the reaction [wogonin results in increased expression of GFAP protein] CTD PMID:23872260 wogonin increases expression ISO GFAP (Homo sapiens) 6480464 wogonin results in increased expression of GFAP protein CTD PMID:23872260 wogonin increases expression EXP 6480464 wogonin results in increased expression of GFAP protein CTD PMID:23872260 wogonin multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [wogonin results in increased expression of GFAP protein] CTD PMID:23872260 ziram multiple interactions ISO Gfap (Mus musculus) 6480464 [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 zonisamide multiple interactions ISO Gfap (Mus musculus) 6480464 zonisamide inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:19199078